| Exercise Capacity and Physical Activity Level in Prolactinoma Patients (NCT05236829) | Hacettepe University | 2021-06-16 |
| Validation of a Quality of Life Metric "Prolac-10" (NCT04106531) | Ohio State University | 2019-10-15 |
| PRolaCT - Three Prolactinoma RCTs (NCT04107480) | Leiden University Medical Center | 2019-06-21 |
| Dopamine D2 Receptors(D2R) Imaging in Prolactinomas (NCT03717454) | Zhebao Wu | 2018-12-01 |
| Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas (NCT03400865) | Zhebao Wu | 2018-10-25 |
| Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma (NCT03457389) | Seoul National University Hospital | 2018-02-22 |
| Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole (NCT03038308) | Columbia University | 2016-09-16 |
| Study on Therapy of Non-invasive Prolactinoma (NCT03353025) | First Affiliated Hospital, Sun Yat-Sen University | 2016-01-01 |
| Seoul National University Pituitary Disease Cohort Study (NCT03474601) | Seoul National University Hospital | 2015-03-15 |
| Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools (NCT01775332) | Unity Health Toronto | 2014-02-01 |
| Rhinological Outcomes in Endonasal Pituitary Surgery (NCT01504399) | St. Joseph's Hospital and Medical Center, Phoenix | 2011-10-01 |
| Insulin Resistance in Women With Prolactinoma (NCT00481299) | Universidade Federal do Rio de Janeiro | 2004-10-01 |
| Clomiphene in Males With Prolactinomas and Persistent Hypogonadism (NCT00697814) | Federal University of São Paulo | 2004-06-01 |
| An Investigation of Pituitary Tumors and Related Hypothalmic Disorders (NCT00001595) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1997-04-21 |